Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-24

Clinical Trial Update: Prevention of HEMOrhagic Risk in Upper MYOmeCTomy by Use of Misoprostol. [NA]

View source ↗

Summary

Clinical trial assessing whether misoprostol reduces hemorrhage risk during myomectomy for uterine fibroids; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MISOPROSTOL (Misoprostol)

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Myoma;Uterus, Myomectomy; Surgical Blood Loss | NA | Status: RECRUITING